Literature DB >> 1382315

Malignant transformation by a mutant of the IFN-inducible dsRNA-dependent protein kinase.

A E Koromilas1, S Roy, G N Barber, M G Katze, N Sonenberg.   

Abstract

The double-stranded RNA-dependent protein kinase (dsRNA-PK) is thought to be a key mediator of the antiviral and antiproliferative effects of interferons (IFNs). Studies examining the physiological function of the kinase suggest that it participates in cell growth and differentiation by regulating protein synthesis. Autophosphorylation and consequent activation of dsRNA-PK in vitro and in vivo result in phosphorylation of the alpha subunit of eukaryotic initiation factor-2 (eIF-2) and inhibition of protein synthesis. Expression of a functionally defective mutant of human dsRNA-PK in NIH 3T3 cells resulted in malignant transformation, suggesting that dsRNA-PK may function as a suppressor of cell proliferation and tumorigenesis.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1382315     DOI: 10.1126/science.1382315

Source DB:  PubMed          Journal:  Science        ISSN: 0036-8075            Impact factor:   47.728


  169 in total

1.  A cis-acting element in the 3'-untranslated region of human TNF-alpha mRNA renders splicing dependent on the activation of protein kinase PKR.

Authors:  F Osman; N Jarrous; Y Ben-Asouli; R Kaempfer
Journal:  Genes Dev       Date:  1999-12-15       Impact factor: 11.361

2.  Phosphorylation of the RNA-dependent protein kinase regulates its RNA-binding activity.

Authors:  N V Jammi; P A Beal
Journal:  Nucleic Acids Res       Date:  2001-07-15       Impact factor: 16.971

3.  The C-terminal, third conserved motif of the protein activator PACT plays an essential role in the activation of double-stranded-RNA-dependent protein kinase (PKR).

Authors:  Xu Huang; Brian Hutchins; Rekha C Patel
Journal:  Biochem J       Date:  2002-08-15       Impact factor: 3.857

4.  The 3'-untranslated regions of cytoskeletal muscle mRNAs inhibit translation by activating the double-stranded RNA-dependent protein kinase PKR.

Authors:  Jean M Nussbaum; Shobha Gunnery; Michael B Mathews
Journal:  Nucleic Acids Res       Date:  2002-03-01       Impact factor: 16.971

5.  Translational control of SCL-isoform expression in hematopoietic lineage choice.

Authors:  Cornelis F Calkhoven; Christine Muller; Richard Martin; Goradz Krosl; Hubertus Pietsch; Trang Hoang; Achim Leutz
Journal:  Genes Dev       Date:  2003-04-15       Impact factor: 11.361

6.  Protein kinase PKR is required for platelet-derived growth factor signaling of c-fos gene expression via Erks and Stat3.

Authors:  A Deb; M Zamanian-Daryoush; Z Xu; S Kadereit; B R Williams
Journal:  EMBO J       Date:  2001-05-15       Impact factor: 11.598

7.  Epstein-Barr virus small RNAs potentiate tumorigenicity of Burkitt lymphoma cells independently of an effect on apoptosis.

Authors:  I K Ruf; P W Rhyne; C Yang; J L Cleveland; J T Sample
Journal:  J Virol       Date:  2000-11       Impact factor: 5.103

8.  Precursor miR-886, a novel noncoding RNA repressed in cancer, associates with PKR and modulates its activity.

Authors:  Kwanbok Lee; Nawapol Kunkeaw; Sung Ho Jeon; Inhan Lee; Betty H Johnson; Gum-Yong Kang; Joo Young Bang; Hyung Soon Park; Chanvit Leelayuwat; Yong Sun Lee
Journal:  RNA       Date:  2011-04-25       Impact factor: 4.942

9.  Analysis of PKR structure by small-angle scattering.

Authors:  Jennifer VanOudenhove; Eric Anderson; Susan Krueger; James L Cole
Journal:  J Mol Biol       Date:  2009-02-14       Impact factor: 5.469

10.  RNA aptamers to initiation factor 4A helicase hinder cap-dependent translation by blocking ATP hydrolysis.

Authors:  Akihiro Oguro; Takashi Ohtsu; Yuri V Svitkin; Nahum Sonenberg; Yoshikazu Nakamura
Journal:  RNA       Date:  2003-04       Impact factor: 4.942

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.